Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 80255 BALTIMORE, MD
Back to LCTX Full portfolio

Position in LCTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$198,115
+$165,536 QoQ
Shares Held
151,233
+108.9% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 130 holders
Holding Since
Mar 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. LCTX ranks #253 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in LCTX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $198,115 151,233
2025-03-31 $32,579 72,398
2024-12-31 $54,102 108,204
2024-09-30 $98,465 108,204
2024-06-30 $165,394 165,394
2024-03-31 $238,744 161,314
2023-12-31 $99,076 90,896
2023-09-30 $100,696 85,336
2023-06-30 $120,323 85,336
2023-03-31 $133,650 89,100
2022-12-31 $104,247 89,100
2022-09-30 $100,683 89,100
2022-06-30 $114,392 72,400
2022-03-31 $94,080 61,091
2021-12-31 $143,057 58,391
2021-09-30 $291,541 115,691
2021-06-30 $153,133 53,731
2021-03-31 $102,930 43,800